G2GBIO is a South Korean biopharmaceutical company focused on long-acting injectable drug delivery technologies, including biodegradable microsphere platforms. It develops and manufactures sustained-release formulations and related pharmaceutical products.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!